S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:GNRX

VanEck Vectors Generic Drugs ETF (GNRX) Price, Holdings, & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$22.42
$22.42
50-Day Range
$22.42
$22.42
52-Week Range
$20.17
$26.19
Volume
4 shs
Average Volume
1,310 shs
Market Capitalization
$3.36 million
Assets Under Management
$3.36 million
Dividend Yield
0.04%
Net Expense Ratio
0.57%

GNRX ETF News Headlines

GDIG ETF Stock Price History
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
VanEck Announces Changes to ETF Product Line
VanEck AEX UCITS ETF (TDT)
GDXJ VanEck Vectors Junior Gold Miners ETF
Generic Drug ETF Can Dodge Biotech Smackdowns
Generic Drug ETF Offering Portfolio Cure
See More Headlines
Receive GNRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Vectors Generic Drugs ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Van Eck
Fund Name
VanEck Vectors Generic Drugs ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:GNRX
Inception Date
1/12/2016
Fund Manager
Hao-Hung (Peter) Liao, Guo Hua (Jason) Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Indxx Global Generics & New Pharma Index
Category
Sector
Focus
Health Care
Development Level
Blended Development
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$3.36 million
Average Daily Volume
$591.00
Discount/Premium
-0.42%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
The Bank of New York Mellon Corporation
Distributor
Van Eck Securities Corporation
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Cantor Fitzgerald

Miscellaneous

Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

VanEck Vectors Generic Drugs ETF Expenses

TypeGNRXHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.56%0.54%0.48%0.51%
Other Expenses2.44%0.40%0.54%0.34%0.58%
Total Expense2.94%0.72%0.70%0.58%0.70%
Fee Waiver-2.37%-0.53%-0.55%-0.22%-0.57%
Net Expense0.57%0.60%0.60%0.54%0.58%

VanEck Vectors Generic Drugs ETF (GNRX) Exposure

GNRX Sector Exposure

GNRX Industry Exposure


GNRX ETF - Frequently Asked Questions

What does GNRX invest in?

VanEck Vectors Generic Drugs ETF is a equity fund issued by Van Eck. GNRX focuses on health care investments and follows the Indxx Global Generics & New Pharma Index. The fund's investments total to approximately $3.36 million assets under management.

What is the management fee for VanEck Vectors Generic Drugs ETF?

VanEck Vectors Generic Drugs ETF's management fee is 0.50% and has other expenses of 2.44%. However, GNRX has a fee waiver of -2.37% to reimburse the expenses. The net expense ratio for GNRX is 0.57%.

What other stocks do shareholders of VanEck Vectors Generic Drugs ETF own?
This page (NASDAQ:GNRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners